Carlyle Group, the new private equity owner of Ortho-Clinical Diagnostics, the former Johnson & Johnson blood testing unit, named Martin Madaus as CEO. The Carlyle Group said it tapped Martin Madaus to take over as CEO of the Ortho-Clinical Diagnostics business it's acquiring from Johnson & Johnson (NYSE:JNJ). Carlyle snaked the business away from several other PE groups who submitted 1st-round bids in September 2013, including Blackstone Group, Kohlberg Kravis Roberts, Bain Capital and BC Partners.
Help employers find you! Check out all the jobs and post your resume.
